MP54-05 EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL. (May 2022)

Record Type:
Journal Article
Title:
MP54-05 EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL. (May 2022)
Main Title:
MP54-05 EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL
Authors:
Mitra, Anirban P.
Mokkapati, Sharada
Miest, Tanner S.
Narayan, Vikram M.
Philipson, Richard
Yla-Herttuala, Seppo
Sawutz, David
Parker, Nigel R.
McConkey, David J.
Dinney, Colin P.N.
Abstract:
Is Part Of:
Journal of urology. Volume 207(2022)Supplement 5
Journal:
Journal of urology
Issue:
Volume 207(2022)Supplement 5
Issue Display:
Volume 207, Issue 5 (2022)
Year:
2022
Volume:
207
Issue:
5
Issue Sort Value:
2022-0207-0005-0000
Page Start:
e927
Page End:
Publication Date:
2022-05
Subjects:
Genitourinary organs -- Periodicals
Urology -- Periodicals
Urology -- Periodicals
Urologie -- Périodiques
Urologie
616.6
Journal URLs:
http://catalog.hathitrust.org/api/volumes/oclc/1754854.html ↗
http://www.jurology.com ↗
http://www.sciencedirect.com/science/journal/00225347 ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1097/JU.0000000000002633.05 ↗
Languages:
English
ISSNs:
0022-5347
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5071.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21850.xml